| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comprehensive salivary analysis for oral cancer diagnosis
|
Shpitzer, Thomas
|
|
2007
|
133 |
9 |
p. 613-617
|
artikel
|
| 2 |
Alcohol, smoking and human papillomavirus in laryngeal carcinoma: a Nordic prospective multicenter study
|
Koskinen, Walter J.
|
|
2007
|
133 |
9 |
p. 673-678
|
artikel
|
| 3 |
Analysing protein–protein interaction networks of human liver cancer cell lines with diverse metastasis potential
|
Zhou, Hai-jun
|
|
2007
|
133 |
9 |
p. 663-672
|
artikel
|
| 4 |
Elevated plasma osteopontin as marker for distant metastases and poor survival in patients with renal cell carcinoma
|
Ramankulov, Azizbek
|
|
2007
|
133 |
9 |
p. 643-652
|
artikel
|
| 5 |
Glutathione peroxidase, glutathione reductase and protein oxidation in patients with glioblastoma multiforme and transitional meningioma
|
Tanriverdi, Taner
|
|
2007
|
133 |
9 |
p. 627-633
|
artikel
|
| 6 |
Induction of Fas (CD95/APO-1) ligand is essential for p53-dependent apoptosis in an in vitro renal carcinoma model system
|
Okazaki, Toshihiko
|
|
2007
|
133 |
9 |
p. 581-588
|
artikel
|
| 7 |
KDR expression is associated with the stage and cigarette smoking of the patients with lung cancer
|
An, She-Juan
|
|
2007
|
133 |
9 |
p. 635-642
|
artikel
|
| 8 |
Markov-modeling for the administration of platinum analogues and paclitaxel as first-line chemotherapy as well as topotecan and liposomal doxorubicin as second-line chemotherapy with epithelial ovarian carcinoma
|
Hartmann, M.
|
|
2007
|
133 |
9 |
p. 619-625
|
artikel
|
| 9 |
Potential tumor markers for human gastric cancer: an elevation of glycan:sulfotransferases and a concomitant loss of α1,2-fucosyltransferase activities
|
Chandrasekaran, E. V.
|
|
2007
|
133 |
9 |
p. 599-611
|
artikel
|
| 10 |
Predictive factors for long-term effects of imatinib therapy in patients with inoperable/metastatic CD117(+) gastrointestinal stromal tumors (GISTs)
|
Rutkowski, Piotr
|
|
2007
|
133 |
9 |
p. 589-597
|
artikel
|
| 11 |
Topotecan, cyclophosphamide, and etoposide (TCE) in the treatment of high-risk neuroblastoma. Results of a phase-II trial
|
Simon, Thorsten
|
|
2007
|
133 |
9 |
p. 653-661
|
artikel
|
Tijdschrift beschrijving